Drug Resistance Mechanisms in Mycobacterium tuberculosis.
about
New agents for the treatment of drug-resistant Mycobacterium tuberculosisMechanisms of first-line antimicrobial resistance in multi-drug and extensively drug resistant strains of Mycobacterium tuberculosis in KwaZulu-Natal, South AfricaNew Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in MycobacteriaGenotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern ThailandComprehensive Whole-Genome Sequencing and Reporting of Drug Resistance Profiles on Clinical Cases of Mycobacterium tuberculosis in New York State.QSAR based therapeutic management of M. tuberculosis.Alphanumerical Visual Display Made of DNA Logic Gates for Drug Susceptibility Testing of Pathogens.A human xenobiotic nuclear receptor contributes to nonresponsiveness of Mycobacterium tuberculosis to the antituberculosis drug rifampicin.Novel Mutations in pncA Gene of Pyrazinamide Resistant Clinical Isolates of Mycobacterium tuberculosis.Genotypic drug resistance using whole-genome sequencing of Mycobacterium tuberculosis clinical isolates from North-western Tanzania.Of Testing and Treatment: Implications of Implementing New Regimens for Multidrug-Resistant Tuberculosis.2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure-Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization.Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care.Advances in nanotechnology-based carrier systems for targeted delivery of bioactive drug molecules with special emphasis on immunotherapy in drug resistant tuberculosis - a critical review.Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis Strains.Transferring knowledge of bacterial protein interaction networks to predict pathogen targeted human genes and immune signaling pathways: a case study on M. tuberculosis.Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebasePredicting bacterial resistance from whole-genome sequences using k-mers and stability selectionTedizolid Activity Against Clinical Complex Isolates-An Characterization Study
P2860
Q26751463-3D07D057-DF65-47E3-8C24-9FBEF541EBA5Q30394537-A375F32F-7071-4F90-B7B3-B046A1F57237Q33600161-23659D67-B99E-4594-A8B7-2E370898C429Q33864972-709792C1-28D6-4D24-9F15-6BEE372CF268Q36337329-F8761956-CD2C-435C-9229-CD744FFBFE51Q36359056-F94B5DB9-D1F1-4100-8FC2-13062F4E6C49Q46247784-E6A05202-63C5-4FEB-8C1F-CC91D21D699FQ49874435-6D20EE36-F392-4698-BF13-D6279450ABA2Q52586133-8D04FA3E-D932-4A76-99EC-00F561DFEBF8Q52646340-AFB0C37D-0CDD-4701-9508-0A8A3CE1EF50Q52648707-30768029-33E0-4410-B49F-7F84D42F6FC4Q52664543-AC2A03E4-2B4C-4572-ADCC-91A85D2A8BFCQ52707803-BE46252A-F8E2-4973-B9FC-4B6099C61144Q53379436-C47A18F0-9EC8-427B-A355-A2D17A72AB06Q55091455-1E76C98E-5F0E-4D7B-AAC3-4D53F228DE45Q55464700-C7193FA3-2A2E-4C1A-988C-84EC3BB53348Q58603045-E3E2F0AB-55EB-40FD-B0F3-5041CC45B7B1Q58605130-C4DDE6FF-15D6-4C06-9631-210C1DAF79A7Q58758954-175ABAEF-E44B-4CDF-818A-09DA3C147D33
P2860
Drug Resistance Mechanisms in Mycobacterium tuberculosis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Drug Resistance Mechanisms in Mycobacterium tuberculosis.
@en
type
label
Drug Resistance Mechanisms in Mycobacterium tuberculosis.
@en
prefLabel
Drug Resistance Mechanisms in Mycobacterium tuberculosis.
@en
P2860
P1476
Drug Resistance Mechanisms in Mycobacterium tuberculosis.
@en
P2093
Anandi Martin
Juan Carlos Palomino
P2860
P304
P356
10.3390/ANTIBIOTICS3030317
P577
2014-07-02T00:00:00Z